InspireMD, Inc. announced that the first carotid artery disease patient has been treated utilizing CGuard Prime, the company's next generation CAS stent platform. The procedure was performed by Dr. Anish Thomas of Mercy Hospital South in St. Louis, MO, as part of InspireMD's ongoing CGuard's ongoing CGuard's U.S. IDE trial.

With the advanced features of the CGuard Prime CAS delivery system, including its innovative handle design, and catheter and tip construction, the ease of stent trackability and deployment have been taken to the next level, which should only accelerate its uptake among interventionalists and surgeons alike. InspireMD anticipates completing enrollment in the CGuard's U. S. IDE trial by the end of the second quarter 2023.